SG191078A1 - Improved method and kit for determining severity and progression of periodontal disease - Google Patents

Improved method and kit for determining severity and progression of periodontal disease Download PDF

Info

Publication number
SG191078A1
SG191078A1 SG2013044383A SG2013044383A SG191078A1 SG 191078 A1 SG191078 A1 SG 191078A1 SG 2013044383 A SG2013044383 A SG 2013044383A SG 2013044383 A SG2013044383 A SG 2013044383A SG 191078 A1 SG191078 A1 SG 191078A1
Authority
SG
Singapore
Prior art keywords
periodontal disease
progression
kit
improved method
patient
Prior art date
Application number
SG2013044383A
Other languages
English (en)
Inventor
Kenneth S Kornman
Xiaodong Wu
Hwa-Ying Wang
Steven Offenbacher
James Beck
John Rogus
Original Assignee
Interleukin Genetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Interleukin Genetics Inc filed Critical Interleukin Genetics Inc
Publication of SG191078A1 publication Critical patent/SG191078A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6827Hybridisation assays for detection of mutation or polymorphism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6858Allele-specific amplification
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/118Prognosis of disease development
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/172Haplotypes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/18Dental and oral disorders

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
SG2013044383A 2010-12-09 2011-12-09 Improved method and kit for determining severity and progression of periodontal disease SG191078A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US42162810P 2010-12-09 2010-12-09
US201161452157P 2011-03-13 2011-03-13
PCT/US2011/064216 WO2012079010A2 (en) 2010-12-09 2011-12-09 Improved method and kit for determining severity and progression of periodontal disease

Publications (1)

Publication Number Publication Date
SG191078A1 true SG191078A1 (en) 2013-07-31

Family

ID=46207769

Family Applications (1)

Application Number Title Priority Date Filing Date
SG2013044383A SG191078A1 (en) 2010-12-09 2011-12-09 Improved method and kit for determining severity and progression of periodontal disease

Country Status (10)

Country Link
US (3) US20120208187A1 (enExample)
EP (1) EP2649203B1 (enExample)
JP (2) JP6138692B2 (enExample)
CN (1) CN103547680B (enExample)
AU (2) AU2011338210B2 (enExample)
BR (1) BR112013014479B1 (enExample)
NZ (2) NZ701432A (enExample)
RU (2) RU2018122965A (enExample)
SG (1) SG191078A1 (enExample)
WO (1) WO2012079010A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106918706B (zh) * 2015-12-25 2019-05-21 广州瑞博奥生物科技有限公司 一种检测牙周病相关蛋白的抗体芯片试剂盒
CA3011363A1 (en) 2016-01-12 2017-07-20 Interleukin Genetics, Inc. Methods for predicting response to treatment
US10329620B2 (en) 2017-01-12 2019-06-25 Cardioforecast Ltd. Methods and kits for treating cardiovascular disease
GB201818627D0 (en) * 2018-11-15 2019-01-02 Mars Inc Analytical systems
JP7097855B2 (ja) * 2019-04-24 2022-07-08 ジェネシスヘルスケア株式会社 歯周病のリスクを判定する方法
CA3142662A1 (en) 2019-06-06 2020-12-10 Sitokine Limited Compositions and methods for treating lung, colorectal and breast cancer
WO2021028469A1 (en) 2019-08-12 2021-02-18 Sitokine Limited Compositions and methods for treating cytokine release syndrome and neurotoxicity
WO2021205013A1 (en) 2020-04-09 2021-10-14 Sitokine Limited Compositions and methods for treating covid-19
KR102571131B1 (ko) * 2021-06-01 2023-08-24 부산대학교 산학협력단 치주염 감별용 바이오마커 조성물, 치주염 중증도 감별용 바이오마커 조성물, 및 이를 이용한 진단 키트
EP4430621A1 (en) * 2021-11-12 2024-09-18 Mars, Incorporated Systems and methods for generating health reports based on veterinary oral care health test

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5110920A (en) 1982-01-22 1992-05-05 Cetus Corporation HLA typing method and DNA probes used therein
US4582788A (en) 1982-01-22 1986-04-15 Cetus Corporation HLA typing method and cDNA probes used therein
US4666828A (en) 1984-08-15 1987-05-19 The General Hospital Corporation Test for Huntington's disease
US4801531A (en) 1985-04-17 1989-01-31 Biotechnology Research Partners, Ltd. Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
US5268267A (en) 1987-08-21 1993-12-07 The General Hospital Corporation Method for diagnosing small cell carcinoma
US5272057A (en) 1988-10-14 1993-12-21 Georgetown University Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
US5328829A (en) 1990-07-05 1994-07-12 Forsyth Dental Infirmary For Children Method of determining sites of active periodontal disease
US5686246A (en) * 1995-08-03 1997-11-11 Kornman; Kenneth S. Detecting genetic predisposition to periodontal disease
GB9711040D0 (en) * 1997-05-29 1997-07-23 Duff Gordon W Prediction of inflammatory disease
US20050282198A1 (en) * 1997-05-29 2005-12-22 Interleukin Genetics, Inc. Diagnostics and therapeutics for diseases associated with an IL-1 inflammatory haplotype
US6130042A (en) * 1998-03-05 2000-10-10 The United States Of America As Represented By The Department Of Health And Human Services Compositions and methods for diagnosing periodontal disease
ES2356167T3 (es) * 2004-05-03 2011-04-05 Interleukin Genetics, Inc. Método de diagnóstico y terapia para enfermedades asociadas con un haplotipo inflamatorio il-1.
US20080118920A1 (en) * 2004-05-03 2008-05-22 Duff Gordon W Diagnostics And Therapeutics For Diseases Associated With An Il-1 Inflammatory Haplotype
EP2304052A2 (en) * 2008-05-02 2011-04-06 Interleukin Genetics, Inc. Detecting genetic predisposition to osteoarthritis associated conditions

Also Published As

Publication number Publication date
JP6138692B2 (ja) 2017-05-31
JP2017121237A (ja) 2017-07-13
JP6622731B2 (ja) 2019-12-18
EP2649203A2 (en) 2013-10-16
AU2016202211B2 (en) 2017-02-23
EP2649203A4 (en) 2014-05-07
CN103547680A (zh) 2014-01-29
AU2016202211A1 (en) 2016-05-05
AU2011338210A1 (en) 2013-07-25
WO2012079010A2 (en) 2012-06-14
RU2018122965A3 (enExample) 2019-04-11
BR112013014479A2 (pt) 2016-09-20
JP2013544536A (ja) 2013-12-19
RU2013131239A (ru) 2015-01-20
US20120208187A1 (en) 2012-08-16
RU2018122965A (ru) 2019-03-06
RU2664431C2 (ru) 2018-08-17
CN103547680B (zh) 2017-05-24
NZ701432A (en) 2016-06-24
BR112013014479B1 (pt) 2020-10-27
US20160244841A1 (en) 2016-08-25
EP2649203B1 (en) 2019-07-24
US9347090B2 (en) 2016-05-24
WO2012079010A3 (en) 2012-08-23
AU2011338210B2 (en) 2016-05-12
NZ612799A (en) 2015-04-24
US20130337448A1 (en) 2013-12-19

Similar Documents

Publication Publication Date Title
SG191078A1 (en) Improved method and kit for determining severity and progression of periodontal disease
NZ589863A (en) Genetic markers for weight management and methods of use thereof
GB2477868A (en) Methods and systems for incorporating multiple environmental and genetic risk factors
NZ590833A (en) Genetic variants for breast cancer risk assessment
MX2009005651A (es) Marcadores geneticos para el manejo de riesgo de la arritmia cardiaca.
WO2009105680A3 (en) Genetic polymorphisms associated with stroke, methods of detection and uses thereof
NZ589034A (en) Detecting genetic predisposition to osteoarthritis associated conditions
WO2005094363A3 (en) System, method and software arrangement for bi-allele haplotype phasing
NZ591236A (en) Methods for determining a breeding value based on a plurality of genetic markers
WO2009047756A3 (en) Methods and kits for diagnosing lung cancer
NZ595640A (en) A method for screening cancer
MX2009012531A (es) Metodos y composiciones para identificar y tratar lupus.
WO2012031207A3 (en) Methods and compositions for correlating genetic markers with prostate cancer risk
MX2007009809A (es) Amplificacion de sonda por seleccion.
NZ599110A (en) Genetic polymorphisms in age-related macular degeneration
WO2010103292A3 (en) A genotyping tool for improving the prognostic and clinical management of ms patients
ATE446385T1 (de) Polymorphismen im nod2/card15 gen
AR069226A1 (es) Asociacion de marcadores geneticos (polimorfismos de un solo nucleotido (snp)) en genes que codifican la subunidad alfa 2 del factor de union al sitio principal (cbfa2t1) y la 2, 4 dienoil coa reductasa 1 (decr1) con meritos de calidad y de aspecto de carne de res
WO2008121825A3 (en) Epidermal growth factor (egf) expression and/or polymorphisms thereof for predicting the risk of developing cancer
WO2005112568A3 (en) Haplotype markers and methods of using the same to determine response to treatment
WO2009097418A3 (en) Sr-bi as a predictor of elevated high density lipoprotein and cardiovascular disease
RU2012144379A (ru) Способ определения наследственной предрасположенности к развитию привычного невынашивания беременности
ES2344396A1 (es) Marcadores geneticos del riesgo de sufrir reestenosis.
WO2009057640A1 (ja) Brca1 関連タンパク質(brap)遺伝子内一塩基多型を用いた炎症性疾患の判定方法
EP1829979A4 (en) METHOD FOR IDENTIFYING A GENE WITH VARIABLE EXPRESSION